| Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children MR Capeding, S Teshome, T Saluja, KA Syed, DR Kim, JY Park, JS Yang, ... Vaccine 36 (26), 3794-3801, 2018 | 39 | 2018 |
| Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia S Teshome, S Desai, JH Kim, D Belay, V Mogasale Human Vaccines & Immunotherapeutics 14 (10), 2427-2433, 2018 | 26 | 2018 |
| Goltz syndrome (focal dermal hypoplasia) with unilateral ocular, cutaneous and skeletal features: case report A Tenkir, S Teshome BMC ophthalmology 10, 1-3, 2010 | 26 | 2010 |
| A randomized, placebo-controlled trial evaluating safety and immunogenicity of the killed, bivalent, whole-cell oral cholera vaccine in Ethiopia SN Desai, Z Akalu, S Teshome, M Teferi, L Yamuah, DR Kim, JS Yang, ... The American journal of tropical medicine and hygiene 93 (3), 527, 2015 | 25 | 2015 |
| Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: phase II, randomized, dose-scheduling, observer-blind study MR Capeding, A Sil, BT Tadesse, T Saluja, S Teshome, E Alberto, ... EClinicalMedicine 27, 2020 | 19 | 2020 |
| Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report MR Capeding, E Alberto, A Sil, T Saluja, S Teshome, DR Kim, JY Park, ... Vaccine 38 (28), 4476-4483, 2020 | 15 | 2020 |
| Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings SN Desai, Z Akalu, M Teferi, B Manna, S Teshome, JY Park, JS Yang, ... Tropical Medicine & International Health 21 (2), 194-201, 2016 | 12 | 2016 |
| A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh F Chowdhury, A Akter, TR Bhuiyan, I Tauheed, S Teshome, A Sil, JY Park, ... Vaccine 40 (4), 640-649, 2022 | 2 | 2022 |
| A randomized, double-blind, controlled trial to evaluate the safety and immunogenicity of killed oral cholera vaccine (Shanchol®) in healthy individuals in Ethiopia SN Desai, Z Akalu, S Teshome, L Yamuah, DR Kim, JS Yang, M Teferi, ... International Journal of Infectious Diseases 21, 431-432, 2014 | 2 | 2014 |
| Spatial delineation of soil erosion vulnerability in Angereb watershed, Amhara Region, Ethiopia S TESHOME | | 2023 |
| Assessment of Soil Erosion Rate and Identification of Hotspot Areas in Angereb Watershed, Abbay Basin, Ethiopia SE Teshome, E Debre Tabor | | 2021 |
| Asses health worker and caregiver interaction during child vaccination sessions at health facilities in Ethiopia: A qualitative study F Bisrat, S Teshome, T Tadesse, M Ayalneh APHA 2021 Annual Meeting and Expo, 2021 | | 2021 |
| Quality of health worker and caregiver interaction during child vaccination sessions: A qualitative study from Benishangul-Gumuz region of Ethiopia S Teshome, L Kidane, A Asress, M Alemu, B Asegidew, F Bisrat Ethiopian Journal of Health Development 34 (2), 2020 | | 2020 |
| A Randomized, Observer-Blinded, Phase I study to Assess the Safety and Immunogenicity of Vi-DT Conjugate Vaccine compared to Vi-Polysaccharide (Typhim Vi®, Sanofi Pasteur … S Teshome, MR Capeding, YH Kim, J Park, J Yeon, DRK Park, Y Chon, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 99 (4), 143-144, 2018 | | 2018 |
